KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers

Summary

This is an First In Human (FIH), observer-blinded, randomized, placebo-controlled, parallel group study to evaluate the safety and immunogenicity of KBP-COVID-19 plus CPG adjuvant vaccine in healthy adult subjects in 2 age groups, Part A (18-49 years) and Part B (50-85 years).

Timeline

Start

2020-12-30

Primary completion

2022-05-31

Completion

2022-10-14

Drugs

Indications